Medical Device News Magazine

NJHA Charts Rise and Fall of COVID Hospitalizations; Peak Occurred April 14

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

NJHA: A new bulletin from the New Jersey Hospital Association reviews the “rise and fall” of COVID-19 in New Jersey hospitals, charting the peak day of hospital activity on April 14 and the steady decline that is bringing the state’s hospitals close to pre-COVID capacity levels.

New Jersey reported its first COVID-19 case on March 4. The rapid rise of the virus in New Jersey culminated on April 14, when the state’s hospitals experienced the following peaks:

  • 8,084 patients were hospitalized with COVID-19
  • 82 percent of intensive care beds were filled
  • 62 percent of ventilators were in use.

These numbers represent a statewide average. However, COVID-19 activity varied significantly across regions of the state, with some facilities in northern New Jersey near 100 percent of capacity in mid-April.

The bulletin includes data through May 20, when 3,208 patients were hospitalized with COVID-19. That’s a 60 percent decline from hospitals’ peak.

“One of the greatest fears – that COVID cases would exceed our available beds and ventilators – never materialized, thanks to hospitals’ nimbleness in expanding capacity in our healthcare system,” said NJHA President and CEO Cathy Bennett. “It’s heartening to see the decline of COVID patients in our hospitals. We remain ever vigilant to not only protect New Jerseyans today, but also to build up our ability to respond to any signs of renewed virus activity.”

Other data in the review from NJHA’s Center for Health Analytics, Research and Transformation, captured through May 20, shows:

  • 150,339 N.J. residents have tested positive for the virus, which represents 1.7 percent of the state’s population. Nationally, more than 1.5 million have been infected, which represents approximately 0.45 percent of the population.
  • 10,747 N.J. residents have died from COVID-19, representing 7.1 percent of the state’s total COVID cases. Across the country, more than 90,000 individuals have died, for a national death rate at just over 6 percent.

Go to www.njha.com/CHART to view the full CHART bulletin.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”